Palisade Bio, Inc.
PALI
$2.14
-$0.01-0.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -31.94M | -24.15M | -16.78M | -11.23M | -11.85M |
| Total Depreciation and Amortization | 1.00K | 2.00K | 3.00K | 3.00K | 3.00K |
| Total Amortization of Deferred Charges | 0.00 | 75.00K | 75.00K | 75.00K | 75.00K |
| Total Other Non-Cash Items | 13.10M | 8.42M | 4.22M | 796.00K | 424.00K |
| Change in Net Operating Assets | 649.00K | 3.25M | 1.64M | 268.00K | 1.68M |
| Cash from Operations | -18.19M | -12.40M | -10.85M | -10.08M | -9.66M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -311.00K | -311.00K | -320.00K | -336.00K | -348.00K |
| Issuance of Common Stock | 139.29M | 139.12M | 135.87M | 8.35M | 4.44M |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.01M | -981.00K | -1.11M | -743.00K | -366.00K |
| Cash from Financing | 137.97M | 137.83M | 134.44M | 7.27M | 3.73M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 119.78M | 125.43M | 123.59M | -2.81M | -5.94M |